$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Beyond their primary bioenergetic roles, mitochondria serve as signaling hubs in multiple cellular processes, including cell differentiation1,2,3,4. Brown adipose tissue (BAT) possesses a notably high mitochondrial mass to support its thermogenic activity, highlighting its role in whole-body energy balance and in the pathogenesis of obesity5. While mitochondrial mass is regulated by the balance between biogenesis and mitophagy, it remains unclear whether mitochondrial mass expansion during brown adipocyte differentiation is functionally required for adipogenesis or merely a consequence of the process.
Physiological mitochondrial transfer between cells has been documented both in vitro and in vivo, where it contributes to tissue adaptation under pathological conditions, including adipose tissue dysfunction associated with obesity and insulin resistance6,7. Furthermore, artificial mitochondrial transfer in vitro has been shown to enhance the respiratory capacity of recipient cells8. Together, these findings support the concept that mitochondrial transfer can modify cellular metabolic function and may contribute to tissue adaptation under conditions of bioenergetic stress9,10,11. Compared with pharmacological or genetic strategies that stimulate endogenous mitochondrial biogenesis by activating nuclear and mitochondrial transcriptional programs, mitochondrial transfer directly delivers organelles to recipient cells, enabling rapid modification of mitochondrial mass independently of transcriptional manipulations12,13. This approach is critical for correcting defects in mitochondrial diseases but also allows to study mitochondrial actions without the potential off-target effects of pharmacological or genetic approaches14.
In the present study, we investigated the effect of artificially increasing the mitochondrial mass by exogenous mitochondrial transfer in differentiating brown adipocytes. This approach enabled direct assessment of the impact of mitochondrial mass on the adipogenic program. To achieve this, mitochondrial transfer protocols originally developed for mesenchymal stem cells were adapted15 using both human hepatic cells and murine preadipocytes as mitochondrial donors. A method for tracking human mitochondria in differentiating mouse cells was developed using genetic tools combined with imaging techniques, demonstrating that mitochondria from both origins are incorporated into the endogenous mitochondrial network and persist throughout adipogenic differentiation.
To model defective adipogenesis associated with low mitochondrial mass, differentiating brown adipocytes derived from 1-acylglycerol-3-phosphate-O-acyltransferase 2 (AGPAT2)-deficient (Agpat2-/-) mice were used. AGPAT2 is highly expressed in adipose tissue, where it catalyzes the formation of phosphatidic acid in the glycerolipid biosynthesis pathway. AGPAT2 deficiency causes severe lipodystrophy in both humans and mice and impairs adipogenesis in white and brown adipocyte models in association with reduced mitochondrial mass16,17,18. Incorporation of exogenous mitochondria into differentiating preadipocytes slightly altered lipid droplet size distribution but did not increase the expression of mature brown adipocyte markers or rescue the adipogenic impairment of Agpat2-/- preadipocytes.